Cibisatamab
Product Specifications
CAS Number
1855925-27-7
Target
Others, Integrin
Related Pathways
Cytoskeletal Signaling, Others
Purity
>99.1%
Bioactivity
Cibisatamab is a T-cell bispecific antibody that acts as a T-cell splicer.Cibisatamab targets carcinoembryonic antigen (CEA) on cancer cells and CD3 on T-cells, and triggers T-cell killing when the CEA on the surface of the cancer cells ranges from intermediate to high levels.Cibisatamab may be used to study solid cancers such as colorectal cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470532-500 1x 500 µL
Cytokeratin 14 (KRT14/532), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
APR16308G 0.1 mg
Polyclonal Goat Anti-ILK (Restricted sale due to demands of patent holder) Antibody
Sign In for Pricing
View Details 463804-01 10 mg
(R) -3-Amino-N- ((R) -4-oxo-1-phenyl-4- (3- (trifluoromethyl) -5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7 (8H) -yl) butan-2-yl) -4- (2,4,5-trifluorophenyl) butanamide
Sign In for Pricing
View Details